1 – 4 of 4
- show: 50
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=" "
width=" "
height=" "
allowtransparency="true"
frameborder="0">
</iframe>
- 2017
-
Mark
Class II Phosphoinositide 3-Kinases as Novel Drug Targets
(
- Contribution to journal › Scientific review
-
Mark
Long-term efficacy and safety of α1 proteinase inhibitor treatment for emphysema caused by severe α1 antitrypsin deficiency : an open-label extension trial (RAPID-OLE)
(
- Contribution to journal › Article
- 2013
-
Mark
State of the Climate in 2012
(
- Contribution to journal › Article
- 2007
-
Mark
Re-discovering PDE3 inhibitors - New opportunities for a long neglected target
(
- Contribution to journal › Scientific review